Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2018 Earnings Conference Call Transcript
Nov 07, 2018 • 04:30 pm ET
Good day, ladies and gentlemen, and welcome to Arbutus Biopharma Corporation 2018 Third Quarter Financial Results and Corporate Update. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to introduce your host for today's conference. Ms. Pam Murphy, you may begin.
Thank you, and good afternoon. Thank you all for joining us. With me today are Dr. Mark Murray, Arbutus' CEO; Dr. Mike Sofia, Arbutus' Chief Scientific Officer; David Hastings, Arbutus' CFO and, Koert VandenEnden, Arbutus' CAO. (Forward-Looking Cautionary Statements) I'd now like to pass the call to Mark for his introductory remarks. Mark?